RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TSHA
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for Taysha Gene Therapies, Inc. stock after losing 4.42%
(Updated on Jul 02, 2024)

Sell candidate since Jun 18, 2024 Loss -27.27% PDF

The Taysha Gene Therapies, Inc. stock price fell by -4.42% on the last day (Tuesday, 2nd Jul 2024) from $2.26 to $2.16. During the last trading day the stock fluctuated 7.94% from a day low at $2.14 to a day high of $2.31. The price has fallen in 6 of the last 10 days and is down by -46.4% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -921 thousand shares and in total, 2 million shares were bought and sold for approximately $4.19 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.08 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 16.09% during the next 3 months and, with a 90% probability hold a price between $2.41 and $4.97 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TSHA Signals & Forecast

There are few to no technical positive signals at the moment. The Taysha Gene Therapies, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.28 and $3.14. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 13, 2024, and so far it has fallen -48.20%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Taysha Gene Therapies, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.04. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.170 between high and low, or 7.94%. For the last week, the stock has had daily average volatility of 11.98%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TSHA) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Taysha Gene Therapies, Inc. to open at $2.20, and during the day (based on 14 day Average True Range), to move between $1.81 and $2.51, which gives a possible trading interval of +/-$0.353 (+/-16.35%) up or down from last closing price. If Taysha Gene Therapies, Inc. takes out the full calculated possible swing range there will be an estimated 32.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.24 (3.70%) than the support at $2.04 (5.56%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Taysha Gene Therapies, Inc. stock A Buy?

The Taysha Gene Therapies, Inc. stock holds several negative signals and despite the positive trend, we believe Taysha Gene Therapies, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.105 Sell Candidate Unchanged

Predicted Opening Price for Taysha Gene Therapies, Inc. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$2.20 ( 2.01%) $2.16

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TSHA

Fibonacci Support & Resistance Levels

Level Price
R3 2.37 9.88%
R2 2.31 6.87%
R1 2.27 5.01%
Price 2.16
S1 2.14 -1.00%
S2 2.10 -2.86%
S3 2.03 -5.86%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.66 23.15%
R2 2.57 18.98%
R1 2.24 3.70%
Price 2.16
S1 2.04 -5.56%
S2 0 -
S3 0 -

FAQ

What is the symbol for Taysha Gene Therapies, Inc. Stock and on which exchange is it traded?
The symbol for Taysha Gene Therapies, Inc. is TSHA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Taysha Gene Therapies, Inc. Stock?
The Taysha Gene Therapies, Inc. stock holds several negative signals and despite the positive trend, we believe Taysha Gene Therapies, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Taysha Gene Therapies, Inc. Stock?
Taysha Gene Therapies, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Taysha Gene Therapies, Inc. Stock.

What's the current price of Taysha Gene Therapies, Inc. Stock?
As of the end of day on the Jul 02, 2024, the price of an Taysha Gene Therapies, Inc. (TSHA) share was $2.16.

What is the 52-week high and low for Taysha Gene Therapies, Inc. Stock?
The 52-week high for Taysha Gene Therapies, Inc. Stock is $4.32 and the 52-week low is $0.615.

What is the market capitalization of Taysha Gene Therapies, Inc. Stock?
As of the Jul 02, 2024, the market capitalization of Taysha Gene Therapies, Inc. is 455.117M.

When is the next earnings date for Taysha Gene Therapies, Inc.?
The upcoming earnings date for Taysha Gene Therapies, Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!

About Taysha Gene Therapies, Inc.

Taysha Gene Therapies. Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of ... TSHA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT